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Background. Severe ischemia/reperfusion (IR) injury is a risk
factor for delayed graft function. Delayed graft function re-
mains difficult to predict, and it currently relies primarily on
serum creatinine (SCr), urine output, and occasionally on graft
biopsy. 1H-NMR (nuclear magnetic resonance spectroscopy)
based metabolomics was used to establish IR-specific metabolic
markers in both blood and kidney tissue. These markers were
compared to SCr and graft histology.
Methods. Male Lewis rats were used for kidney transplan-
tation. Two cold ischemia (CI) groups (24- and 42-hour) and
two transplantation groups [after 24 (TX24) and after 42 hours
(TX42) of CI] were compared to a control group. Whole blood
and kidney tissue were collected for further analysis.
Results. SCr levels taken 24 hours after transplantation were
1.6 ± 0.12 mg/dL (TX24) and 2.1 ± 0.5 mg/dL (TX42), (P =
n.s.). Histology samples revealed mild injury in the TX24 group
and severe injury in the TX42 group. A significantly decreased
level of polyunsaturated fatty acids (PUFA) and elevated levels
of allantoin, a marker of oxidative stress, was found in the re-
nal tissue. In the blood, both trimethylamine-N-oxide (TMAO),
a marker of renal medullary injury, and allantoin were signifi-
cantly increased. Allantoin levels were low in both the control
and CI groups. Levels were significantly increased after reperfu-
sion (control 0.02 ± 0.03 lmol/mL, TX24 1.13 ± 0.22, and TX42
1.89 ± 0.38, P < 0.001), and correlated with cold ischemia time
(r = 0.96) and TMAO (r = 0.94).
Conclusion. The 1H-NMR metabolic profiles of both the mild
and severe IR groups revealed significant changes consistent
with graft histology, while the SCr did not.
Renal transplantation has several major post-
transplant complications, which include delayed graft
function (DGF), toxicity of calcineurin inhibitors, acute
and chronic graft rejection. These can contribute to im-
Key words: oxidative stress, allantoin, ischemia reperfusion injury.
Received for publication April 15, 2004
and in revised form July 15, 2004
Accepted for publication September 28, 2004
C© 2005 by the International Society of Nephrology
mediate postoperative compromise in graft function and
even graft loss. A prolonged cold ischemia time has been
shown to contribute to DGF. Delayed graft function is
known to be an independent risk factor for acute rejec-
tion and is considered along with acute rejection and old
donor age to be a predictor of late graft failure [1–3].
Unfortunately, DGF appears to amplify the detrimen-
tal effects of old donor age on long-term graft outcome
[4]. Currently, urine output and serial serum creatinine
(SCr), both nonspecific indicators of kidney function, are
most commonly used to detect DGF. The distinction be-
tween DGF and acute rejection within the first 24 hours of
transplantation remains difficult and frequently requires
renal biopsy. An accurate, early, noninvasive method that
can detect the severity of ischemia/reperfusion (IR) in-
jury would not only facilitate management, but could also
help to distinguish poor renal function that is secondary
to acute rejection.
Several isolated metabolites in the blood and urine
have been found to be indicators of kidney injury fol-
lowing transplantation. These metabolites are intermedi-
ates or end products of cellular processes and, therefore,
reflect the global integrated response of an organ or
entire biological system to pathophysiologic stimuli [5].
Nuclear magnetic resonance spectroscopy (NMR) has
been shown in different studies to predict long-term out-
come of renal grafts based on energy state in vivo [6],
and may be able to document medullary injury based
on metabolic markers ex vivo [7, 8]. However, signifi-
cant information may be missed if obtained metabolic
profiles cannot be integrated into the clinical context.
One may be able to demonstrate renal injury by NMR,
but will not necessarily be able to distinguish the eti-
ology. Different well-established metabolic end points
that can identify a particular pathophysiologic stage will
be required for the accurate diagnosis of specific dis-
ease processes. The determination of these profiles, pri-
marily using blood, is termed metabolomics, and this
may allow insight into complex clinical scenarios. Indeed,
1H-NMR–based metabolomics is a promising approach
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used to investigate and analyze complex multiparamet-
ric metabolic data [9, 10]. It has been recently used to
distinguish serum metabolic markers that predict coro-
nary artery disease and hypertension [10]. In the area of
kidney transplantation, various NMR-based publications
have reported trimethylamine-N-oxide (TMAO) to be a
urine marker for nonspecific medullar injury [7, 8, 11, 12].
Using 1H-NMR–based quantitative metabolomics, it
was our goal in the present study (1) to distinguish
metabolic markers for IR injury in a rat kidney trans-
plant model; (2) to establish concentration ranges for dis-
tinguished markers that correlate with the degree of IR
injury; and most importantly (3) to compare our findings
with clinically commonly used end points such as SCr and
graft histology.
METHODS
Definition of mild and severe ischemic injury
We previously determined the relationship between
duration of cold storage in UW and rat kidney graft sur-
vival. The survival rate of grafts with 24-hour cold stor-
age (mild ischemic injury) was 100%. The survival rate of
42-hour cold-stored grafts (severe ischemic injury) was
only 40% [13]. In the severe ischemia reperfusion group,
recipients of renal grafts typically died of renal failure
between postoperative day 2 and 3.
Animal surgery
All animal experiments were carried out at the Uni-
versity of California at San Francisco with approval by
the UCSF Committee on Animal Research. Animal care
was in agreement with the National Institute of Health
guidelines for ethical research (NIH publication no. 80–
123, revised 1985). Inbred male Lewis rats (200–250 g
body weight) were used as both donors and recipients
for heterotopic kidney transplantation. Donor animals
were anesthetized with isoflurane, and the left kidney
was exposed through a midline incision. Following mobi-
lization of the left kidney, an arterial flush catheter was
then placed in the abdominal aorta. Both kidneys were
flushed with University of Wisconsin solution (UW solu-
tion, DuPont, Wilmington, DE, USA) after the clamping
of the suprarenal aorta and incision of the vena cava.
Both kidneys were removed and placed in cold UW so-
lution. After the end of cold ischemia time, the right
kidney was snap frozen in liquid nitrogen for 1H-NMR
analyses of “cold ischemia” kidney extracts. The left kid-
ney was used for transplantation. The recipient animal
was anesthetized with isoflurane. Before transplantation,
blood samples (“native”) were collected from the recipi-
ent. Through a midline incision, the native kidneys were
exposed, removed, and snap frozen for 1H-NMR analy-
ses of “native” kidney extracts. The recipient’s abdominal
aorta and vena cava were then exposed, and an end-to-
side anastomosis between the donor renal vessels (using
an aortic patch) and the recipient aorta and vena cava
was performed. An end-to-end anastomosis between the
donor and the recipient ureter was performed. All recipi-
ents were sacrificed 24 hours after transplantation. Blood
and kidney samples were snap frozen in liquid nitrogen
for further 1H-NMR analysis.
Study groups
Renal tissue was examined in 5 different groups: na-
tive (NAT, N = 8); 24 hours of cold ischemia only (CI24,
N = 6), 42 hours of cold ischemia only (CI42, N = 6), and
cold ischemia (24-hour, 42-hour) followed by transplan-
tation and 24 hours of reperfusion, (TX24, N = 8) and
(TX42, N = 6). Blood was analyzed in native rats (NAT)
and in recipient rats after transplantation and reperfusion
(TX24 and TX42).
Graft function and histology
In the native group, blood samples for SCr measure-
ment were taken from the recipient before transplan-
tation, while in the 24- and 42-hour group the samples
were from the time of sacrifice. Kidney cross-sections
were fixed in buffered formalin, embedded in paraffin,
and stained with hematoxylin-eosin for histologic evalu-
ation under a light microscope.
Animal recovery after surgery
Recipient recovery was closely monitored. Animal be-
havior and appearance were assessed 1 hour, 3 hours,
12 hours, and 24 hours after surgery. The clinical signs of
poor initial graft function and ill-appearing animals in-
cluded a lack of urine production, lethargy, ruffled fur,
and guarding upon abdominal palpation. Upon sacrifice,
all animals underwent necropsy. Animals with intra-
abdominal pathology such as hemorrhage, bowel obstruc-
tion, and urine leak were excluded from the study.
Kidney acid extraction for NMR
Kidney tissues were snap frozen in liquid nitrogen and
extracted using 12% perchloric acid (PCA) according to
a protocol developed in our laboratory [14]. Briefly, 0.2
to 0.8 g of frozen kidney tissue was used per a PCA ex-
tract. Tissues were weighed and powdered in a mortar in
the presence of liquid nitrogen before 4 mL of ice-cold
PCA was added. The samples were vortexed, homoge-
nized using an electrical homogenizer, and centrifuged
for 20 minutes at 1300g at 4◦C. The supernatants were
collected and the pellets were redissolved with 2 mL
PCA before being vortexed and centrifuged. The su-
pernatants were combined, neutralized to pH 7 using
potassium hydroxide (KOH), and centrifuged again to
remove potassium perchlorate. The supernatants that
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contained water-soluble endogenous metabolites were
then lyophilized overnight to remove water for NMR
experiments. The water-soluble extracts were then dis-
solved in 0.45 mL of deuterium oxide (D2O) prior to
1H-NMR. The pH of each extract inside of the 5-mm
NMR tube was checked using a thin pH electrode. If nec-
essary, deuterated chloride (DCl) and sodium hydrogen
(NaOD) were added to adjust pH = 7.
After the second centrifugation, the pellets were re-
dissolved in 4 mL ice-cold water and pH = 7 was ad-
justed using KOH. The pellet suspensions that contained
lipid fraction were then lyophilized overnight to remove
water for NMR experiments. The lipid extracts were
dissolved in 1 mL of deuterated chloroform/methanol
mixture (2:1, vol/vol) prior to 1H-NMR.
Blood methanol/chloroform extraction for NMR
All blood samples were processed using dual chlo-
roform/methanol extraction [15]. One mL of heparin-
preserved whole blood was carefully vortexed and
processed with 2 mL of cold chloroform/methanol (1:1,
vol/vol). After centrifugation, the supernatants were col-
lected and the pellets were resuspended with 1 mL
of chloroform/methanol, centrifuged, and the super-
natants were collected. The supernatant was washed with
1 mL ice-cold water. The water phase was removed
and added to the pellet. Two mL of water was added,
and the pellet was centrifuged, and the supernatant
was lyophilized overnight (water-soluble extracts). Af-
terwards, the water-soluble part was dissolved in 0.45 mL
D2O and analyzed by proton NMR. The lipids in the or-
ganic phase were evaporated to dryness under a stream
of nitrogen at 50◦C. The lipid extracts were dissolved in
0.6 mL of deuterated chloroform/methanol (2:1, vol/vol)
for NMR analysis.
Proton quantitative NMR on blood and kidney extracts
All water-soluble and lipid extracts from kidney and
blood tissue were analyzed using a 500 MHz high-
resolution Bruker DRX system (Bruker Biospin, Inc.,
Fremont, CA, USA). An inverse TXI 5-mm probe-
head was used for all experiments. In order to suppress
water residue in extracts, a standard Bruker water pre-
saturation sequence was used (“zgpr”) (operating fre-
quency for proton channel: 500.24 MHz; power level
pl1 = 3 dB; power level for water suppression pl9 = 55 dB;
power angle p1 = 7.5 lsec (90◦ pulse); power angle for wa-
ter suppression p12 = 60 ls; water suppression at O1 =
4.76 ppm; relaxation delay d1 = 12.85 sec (5×T1); de-
lay for power switching d12 = 20 ls; short delay d13 =
3 ls; spectral width sw = 12 ppm; total number of scans
ns = 40). An external standard substance, trimethylsi-
lyl propionic-2,2,3,3,-d4 acid (TMSP, 20 and 50 mmol/L
in D2O) was added into a thin glass capillary. The final
TMSP concentration (0.5 mmol/L and 1.2 mmol/L) in the
capillary was calculated prior to NMR experiments on
study extracts using a standard amino acid solution. The
TMSP capillary was placed into the NMR tube during
the experiment (0.5 mmol/L for water-soluble extracts
and 1.2 mmol/L for lipid extracts), and served as an ex-
ternal standard which allowed for absolute metabolite
quantification in each study extract. 1H chemical shifts
were referred to TMSP signal at 0 ppm. After perform-
ing Fourier transformation and making phase and base-
line corrections, each 1H peak was integrated using 1D
WINNMR program (Bruker Biospin, Inc., Fremont, CA,
USA). The absolute concentrations of single metabolites
were then referred to the TMSP integral and calculated
according to equation 1:
Cx = Ix : Nx × C
I : 9
× V : M (1)
where Cx = metabolite concentration, Ix = integral of
metabolite 1H peak, Nx = number of protons in metabo-
lite 1H peak (from CH, CH2, CH3), C = TMSP concen-
tration, I = integral of TMSP 1H peak at 0 ppm (:9 since
TMSP has 9 protons), V = volume of the extract, M =
weight of kidney tissue or volume of blood sample.
Statistical analysis
All data are present as mean ± standard deviations.
Stepwise logistic regression modeling was performed in
order to distinguish a specific marker in outcome based
on values of a set of predictor variables as widely de-
scribed in the literature [16]. In addition, a correlation
analysis between the absolute concentrations of distin-
guished markers and cold ischemia time (t1 = 24 and t2 =
42) was performed using SPSS 11.5. One-way analysis of
variance (ANOVA) test (SPSS 11.5; SPSS, Inc., Chicago,
IL, USA) was performed in order to evaluate statisti-
cally significant changes in metabolites between the study
groups. The P value <0.05 was recognized as being sta-
tistically significant. Postoperative SCr were compared to
native groups using ANOVA with Dunnett’s correction.
RESULTS
Animal recovery after surgery
All recipients with 24-hour cold stored kidneys (N =
6) fully recovered 1 hour after surgery as assessed by am-
bulation, grooming, drinking, and feeding. All animals in
this group showed good urine production on postopera-
tive day 1. Two recipients in the 42-hour cold ischemia
group also demonstrated a quick recovery from surgery
that was comparable to animals in the 24-hour group.
Four animals in the 42-hour cold ischemia group showed
slow recovery. A lack of urine production, lethargy, ruf-
fled fur, and guarding upon abdominal palpation was
present in all 4 animals. However, none of the animals
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Fig. 1. (A) Representative light micrographs of native kidneys with
no ischemia reperfusion injury. (B) Representative light micrographs
of 24 hour cold-stored rat kidney grafts 24 hours after transplantation.
Mild to moderate IR injury resulted in proximal tubular dilatation with
died before the end of the observation period. There
was no difference in body weight between animals after
24 hours of transplantation.
Serum creatinine levels after 24 hours of reperfusion
Serum creatinine in sham operated rats was 0.47 ±
0.1 mg/dL. Twenty-four hours after transplantation SCr
was not different for grafts after 24 or 42 hours of cold
ischemia. Mean SCr was 2.1 ± 0.48 mg/dL in the TX42
group and 1.6 ± 0.12 mg/dL in the TX24 group (P = n.s.).
Both were significantly higher than in control animals
(P < 0.01). The two rats in the 42-hour cold ischemia/
24-hour reperfusion group that appeared to be in better
clinical condition had lower SCr levels.
Graft histology
Grafts subjected to either 24 hours or 42 hours of cold
storage presented with different patterns of histologic
damage after 24 hours of transplantation. The proximal
tubules, which are predominantly located in the outer
medulla, are known to be most susceptible to ischemia
reperfusion injury, while the renal cortex remains largely
unaffected. Grafts subjected to 24 hours of cold storage
prior to transplantation (TX24) showed mild to mod-
erate histologic damage, presenting as proximal tubu-
lar dilatation and epithelial casts formation (Fig. 1B).
In contrast, 42-hour cold stored grafts (TX42) showed
irreversible damage in most cases. Typically, the outer
medulla showed large areas of frank tubular necrosis
surrounded by viable but severely damaged proximal
tubules (Fig. 1C).
Metabolic changes in kidney tissues
Over 30 metabolites were identified and quantified
from kidney extracts by 1H-NMR. The absolute con-
centrations of major endogenous metabolites from na-
tive kidney extracts are presented in Table 1. The
determination of the baseline metabolic profiles in
normal kidney tissue is crucial in order to allow for the
comparison to injured kidneys. Renal tissue contained
carbohydrates (glycogen and glucose) and triglycerides
as their nutritional source. There was no hydroxybu-
tyrate (ketone bodies). High concentrations of cellular
osmolytes such as inositol, betaine, TMAO, and taurine
were detected in the native kidney, as well as intermediate
amino acids from the citrate cycle (glutamate, glutamine,
citrate, aspartate). End products of glycolysis (lactate
few epithelial casts (arrows). (B) also shows a widely intact tubular
architecture in the outer medulla. (C) Representative light micrographs
of 42-hour cold-stored rat kidney grafts 24 hours after transplantation.
Severe I/R injury caused widespread necrosis of proximal tubular cells.
(C) also shows the outer medulla with bandlike areas of frank tubular
necrosis and congested capillaries.
1146 Serkova et al: Allantoin in rat kidney transplantation
Table 1. Absolute concentrations of major endogenous metabolites quantified from native blood and kidney extract by 1H-NMR
Metabolites Chemical shift ppm Kidney lmol/g Blood lmol/mL
Acetate 1.95 0.09 ± 0.10 0.17 ± 0.02
Alanine 1.48 1.05 ± 0.20 0.65 ± 0.03
Allantoin 5.39 0.34 ± 0.16 0.02 ± 0.03
Asparagine 2.96, 4.00 n.d. 0.42 ± 0.26
Aspartate 2.82+2.68 0.56 ± 0.09 n.d.
Betaine/CH3 3.26 1.16 ± 0.21(+TMAO) n.d.
3-OH-butyrate 1.20 n.d. 0.08 ± 0.03
Citrate 2.80 + 2.67 0.91 ± 1.15 0.42 ± 0.09
Citrulline 1.58, 3.15 n.d. 0.72 ± 0.07
Cholesterol 0.69 6.91 ± 1.00 1.90 ± 0.10
Cholines 3.21 14.23 ± 1.98 1.35 ± 0.15
Creatinine+creatine 3.02 − 3.04 0.79 ± 0.22 0.23 ± 0.08
Dimethylamide 2.72 0.06 ± 0.06 n.d.
Glucose 5.23 + 4.64 2.87 ± 0.42 4.16 ± 1.35
Glutamate 2.36 3.01 ± 0.57 0.33 ± 0.10
Glutamine 2.46 1.05 ± 0.19 0.29 ± 0.08
Glutathione (GSH) 2.53 0.84 ± 0.22 0.31 ± 0.11
Glycerol-6-phosphate 3.99 12.57 ± 2.17 1.06 ± 0.24
Glycerophosphocholine 3.23 0.99 ± 0.11 n.d.
Glycogen 5.41 0.34 ± 0.04 n.d.
Inositol 4.06 2.72 ± 1.08 n.d.
Lactate 1.32 1.75 ± 0.28 1.31 ± 0.39
Monounsaturated fatty acids (MUFA) 5.42 (with PUFA) 10.30 ± 2.72 1.11 ± 0.07
Phosphatidylcholine 3.57 3.13 ± 0.42 0.28 ± 0.06
Phosphatidylethanolamine 3.10 1.15 ± 0.22 n.d.
Polyunsaturated fatty acids (PUFA) 2.84 78.52 ± 13.02 8.12 ± 0.72
Pyruvate 2.38 1.40 ± 0.57 0.36 ± 0.05
Taurine 3.43 4.91 ± 1.20 n.d.
Total triglycerides (TG) 0.88 119.87 ± 30.22 13.22 ± 2.88
Triacylglycerol (TAG) 4.16 10.17 ± 4.17 1.02 ± 0.34
Trimethylamide 2.88 n.d. 0.01 ± 0.02
Trimethylamine-N-oxide (TMAO)/CH3 3.27 1.16 ± 0.21 (+betaine) 0.24 ± 0.04
Valine+leucine+isoleucine 0.99 − 1.04 3.17 ± 1.50 1.18 ± 0.19
n.d., nondetectable. TMAO and betaine concentrations are based on three CH3 groups.
Table 2. Changes in distinguished metabolic markers of I/R in rat kidney tissue in ischemic (CI24, CI42) and transplant groups (TX24, TX42)
Kidney metabolites NAT CI24 CI42 TX24 TX42
Allantoin 0.34 ± 0.16 0.02 ± 0.05a 0.02 ± 0.06a 1.89 ± 0.49a,b 2.62 ± 0.19a,b,c
PUFA 78.52 ± 13.02 64.91 ± 12.00 54.27 ± 13.46a 51.04 ± 3.51a,b 38.91 ± 8.60a,c
PUFA, polyunsaturated fatty acids. All data are given as mean ± SD. The concentrations are given as lmol/g.
aP < 0.01 to the control group.
bP < 0.05 to the corresponding cold ischemia groups.
cP < 0.02 between TX24 and TX42.
and alanine) were present in the kidney. Kidney tissues
also contained high concentrations of lipid metabolites
(triglycerides, cholesterol, poly- and monounsaturated
fatty acids).
Cold storage in UW solution significantly changed the
metabolic composition of the kidney. A significant in-
crease in glycogen and other carbohydrates (P < 0.0001
vs. native kidney) was observed at 24 and 42 hours of
cold ischemia. As expected, the lactate concentration was
greatly increased, up to 380% during cold ischemia. In the
lipid extracts, a decrease of polyunsaturated fatty acids
(PUFA) was seen in cold ischemia groups versus native
kidney (spectra not shown, Table 2). There were no sig-
nificant differences in metabolic composition at the end
of 24 and 42 hours of cold ischemia time (groups CI24
and CI42), indicating that after 24 hours of cold storage,
kidneys had already switched their metabolism to adapt
for ischemic conditions.
Transplanted kidneys exposed to reperfusion for
24 hours (TX24 and TX42) demonstrated characteris-
tic changes in their metabolic profiles. The most pro-
nounced difference between the TX and CI groups was
the dramatic increase of an initially not identified peak at
5.39 ppm (Fig. 2). Peak identification was performed us-
ing two-dimensional 2D-H,C-HSQC NMR, which allows
for the exact structure analysis (chemical shifts for allan-
toin: r1H = 5.39 ppm; d13C = 66 ppm). It was identified
as a (CH) group of allantoin (Fig. 4), the end product of
xanthine metabolism and uric acid, and a marker of ox-
idative stress. In order to confirm the identified structure
we also ran HSQC on a standard solution of 10 mmol/L
allantoin (Sigma Aldrich, St. Louis, MO, USA).
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Fig. 2. Representative 1H-NMR of kidney
extracts. (A) Native kidney (NAT). (B)
Twenty-four hours of cold ischemia (CI24).
(C) Twenty-four hours after transplantation
followed after 24 hours of cold ischemia
(TX24). TMAO, trimethylamine-N-oxide.
Allantoin concentrations were low in the native kidney
(0.34 ± 0.16 lmol/g tissue) and at the end of cold ischemia
(range 0.02 to 0.12 lmol/g for 24 to 42 hours). Allantoin
levels increased significantly after 24 hours of reperfusion
(1.89 ± 0.49 lmol/g in TX24 and 2.62 ± 0.19 lmol/g in
TX42, P < 0.01 between TX24 and TX42; Table 2). The
stepwise logistic regression analysis revealed that from 30
metabolites quantified from kidney extracts, only two—
allantoin and PUFA—were different among study groups
(Table 2 and Fig. 3A). Even though significant allantoin
concentrations appeared only after reperfusion, its con-
centrations correlated well with cold ischemia times (r =
0.95). A three-dimensional group distribution based on
allantoin, PUFA concentrations, and cold ischemia time
allowed for visual cluster analysis of the 5 study groups
(Fig. 3A).
Metabolic changes in rat blood
From blood extracts, over 50 metabolites were identi-
fied and quantified. Out of 8 animals in the native group
(Table 1), allantoin concentrations were below the limit
of quantification for NMR in the blood of 6 animals. Al-
lantoin peaks appeared in the blood in both TX24 and
TX42 group following reperfusion (Fig. 2). Allantoin con-
centrations were significantly higher in transplanted rats
with 42-hour cold storage when compared with 24-hour
cold storage (Table 3, P < 0.002). The correlation coeffi-
cient for allantoin concentrations was excellent for cold
ischemia time (r = 0.96).
The allantoin concentrations in 2 TX42 rats with good
initial graft function as determined by clinical appear-
ance, SCr, and urine output were lower in comparison
with the concentrations in 4 rats from the same group
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Fig. 3. (A) Distribution of study groups
based on endogenous concentrations of allan-
toin and PUFA in rat kidney as function of
cold ischemia time. Correlation with ischemia
time: r = 0.95 (allantoin), r = −0.91 (PUFA);
correlation between allantoin and PUFA:
r = −0.87. (B) Distribution of study groups
based on endogenous concentrations of allan-
toin and TMAO in rat blood as function of
cold ischemia time. Correlation with ischemia
time: r = 0.96 (allantoin), r = 0.94 (TMAO);
correlation between allantoin and PUFA: r =
0.94. Abbreviations: PUFA, polyunsaturated
fatty acids; TMAO, trimetylamidne-N-oxide.
who had signs of poor initial graft function (Fig. 3B).
The allantoin concentrations in these 2 rats were 1.52 and
1.33 lmol/mL compared to 1.99 to 2.32 lmol/mL in the
4 rats with poor function.
A second metabolic blood marker, trimethylamidox-
ide (TMAO), which was identified by logistic regression
correlated well with cold ischemia time (r = 0.94). TMAO
is a nonspecific marker of medullary injury, and its con-
centration correlated well with elevated allantoin levels
(r = 0.95).
Because allantoin is a direct product of uric acid, we
determined the concentrations of uric acid in rat serum
from NAT, TX24, and TX42 groups. We used an enzy-
matic assay since uric acid has no CH-bounded groups
and, as such, produces no NMR signal. However, uric
acid concentrations were below the linear range for the
assay and, therefore, of no significance.
DISCUSSION
The attempt to distinguish the etiologies of poor initial
function of renal grafts has led to an increasing number
of studies. Detection of DGF currently relies mainly on
Table 3. Changes in distinguished metabolic markers in rat blood in
transplant groups (TX24, TX42)
Blood metabolites NAT TX24 TX42
Allantoin 0.02 ± 0.03 1.13 ± 0.22a 1.89 ± 0.38a,b
TMAO 0.24 ± 0.04 1.79 ± 0.42a 2.45 ± 0.32a,b
TMAO, trimetylamine-N-oxide. All data are given as mean ± SD. The
concentrations are given as lmol/mL.
aP < 0.00001 to the control group.
bP < 0.005 between TX24 and TX42.
serial SCr measurements and urine output, but this ap-
proach cannot distinguish between DGF, acute rejection,
and drug nephrotoxicity. Knowledge about the etiology
of poor postoperative graft function is necessary for clin-
ical decision-making, including the choice of immuno-
suppressive therapy. At times, renal biopsy is required to
determine the etiology of impaired graft function. Using
specific metabolic changes in peripheral blood to identify
DGF may have important clinical implications, largely
because this method is relatively noninvasive. It is un-
likely that diagnostic blood tests will be able to entirely
replace renal biopsy, but they may prove to be adequate
in the majority of cases.
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idase leads to increased degradation of xan-
thines. Accumulation of end products allan-
toin (in mammals) can be used as a sensitive
marker for reperfusion injury in rat kidney
transplantation. In humans, allantoin is pro-
duced by the chemical reaction between uric
acid and H2O2 since uricase is not present.
Allantoin (molecular weight: 158.12) is de-
tectable a singlet at 5.39 ppm in 1H-NMR (66
ppm in 13C-NMR).
Proton-NMR spectroscopic analysis allows for the si-
multaneous detection, identification, and quantification
of hundreds of low-molecular-weight (max. 20 kD)
metabolites within a biological matrix [15]. The use of
NMR-based metabolomics on tissue biopsies and body
fluids allows for the assessment of dynamic changes in
global metabolism and, specifically, for noninvasive blood
markers, which represents a novel and robust method of
assessing organ response to pathophysiologic stimuli [5,
10, 17]. Several publications have demonstrated the feasi-
bility of NMR for evaluating different clinical scenarios in
transplantation [8, 12]. Most publications have reported
the relative ratios of one metabolite to another, which,
due to the complicated dynamic changes in metabolism,
can often overlook significant changes.
Previous studies have reported the production of re-
active oxygen species (ROS), lipid peroxidation, and
antioxidant capacity in renal transplantation [18–22].
However, the interpretation and comparison (e.g., lipid
peroxidation between groups) of a single metabolic end
point can be confounded by variations in either experi-
mental or physiologic status. For example, oxidative stress
is not only seen with IR during kidney transplantation,
but also with diabetes [23] and hypertension [24]. The
interpretation is further complicated by the fact that
both hypertension and diabetes are often simultaneously
present in kidney recipients.
Reactive oxygen radicals are produced by different
pathways. These pathways include various enzymes such
as lipoxygenases, peroxidases, NADPH oxidase, and
xanthine oxidase. Xanthine oxidase is a molybdenum-
requiring enzyme that uses molecular oxygen and pro-
duces H2O2, which in turn may be used for further
reactions in the xanthine pathway in humans (Fig. 4).
Up-regulation of the xanthine pathway has been demon-
strated to be an important contributor to oxidative stress
in transplantation, burn traumas, pulmonary endothelial
cells exposed to tobacco smoke, and hypertensive and
global ischemia models [24].
As expected, we did not detect any metabolic differ-
ences between the cold storage periods without reper-
fusion that were due to oxidative stress. Only after the
reperfusion of the graft did the different levels of ox-
idative stress become apparent. Twenty-four hours after
cold storage and transplantation, we were able to dis-
tinguish allantoin, a marker of oxidative stress after is-
chemia/reperfusion, not only in renal tissue but also in
blood. In mammals, allantoin is a metabolic end prod-
uct of uric acid and, therefore, of xanthine metabolism
(Fig. 4). The levels of allantoin after reperfusion corre-
lated strongly with the duration of cold ischemia. The in-
creased concentrations of allantoin after the reperfusion
of the ischemic kidney indicate up-regulation of xanthine
oxidase with increased degradation of xanthines. Uricase
(the enzyme which catalyzes the reaction from uric acid
to allantoin) is highly active in mammals and, therefore,
uric acid was not detected in rat plasma in our study.
In humans, by contrast, uricase activity has not been re-
ported, but allantoin has been documented. The detec-
tion of allantoin in humans is likely to be secondary to
a nonenzymatic reaction, as shown in Figure 4. Several
studies involving diabetic human subjects and volunteers
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under extreme exercise have demonstrated elevated al-
lantoin concentrations that can be attributed to oxidative
stress [23, 25]. Furthermore, the preliminary results from
a clinical study performed at our institution indicate that
the recipients of cadaveric renal allografts that have had
prolonged cold ischemia may experience elevated allan-
toin as well as uric acid concentrations 24 hours after
transplantation (data not shown). In the present study,
the high concentrations of allantoin in rat renal grafts
might have 2 possible explanations: the increased degra-
dation in xanthine pathways through uricase (not present
in humans, but elevated uric acid concentrations can be
expected); and an increased H2O2 production through a
chemical pathway (can be expected in human recipients).
Similarly, decreased PUFA levels were observed in re-
nal grafts, which were inversely correlated with allan-
toin levels. Tissue concentrations of PUFA have been
shown to be a sensitive marker of lipid peroxidation
[26, 27]. PUFA are the fatty acids that undergo per-
oxidation under oxidative stress conditions. Therefore,
their decreased concentrations are a marker for increased
lipid peroxidation. During ischemia/reperfusion injury,
lipid peroxidation is increased in the tissue, while PUFA
concentrations are greatly decreased [27]. Markedly de-
creased PUFA levels were seen in the TX42 group
(38.91 ± 8.60 vs. 78.52 ± 13.02 lmol/g when compared
with native kidney, P = 0.0001). In contrast, the TX24
group had significantly higher PUFA levels (51.04 ± 3.51
vs. 38.91 ± 8.60 when compared to TX42 group, P =
0.0163), which indicates a lower degree of lipid peroxi-
dation. After 42 hours of cold ischemia and 24 hours of
reperfusion, the kidney still experienced significantly el-
evated levels of oxidative stress. However, these findings
in renal tissue are unlikely to offer any advantage over
the classical histologic analysis of kidney biopsies.
Blood allantoin levels were highly correlated with
the degree of renal medullary injury as determined by
TMAO. The osmolyte, TMAO, is synthesized in the renal
medulla and is an established marker of medullary renal
injury. Hauet et al demonstrated in several studies that
TMAO correlated with the degree of renal injury inflicted
by different mechanisms. Most relevant to the present
study was their finding that metabolic markers of injury
significantly increased with the duration of cold ischemia
and different preservation solutions [7, 8, 12]. While to
a certain extent the degree of medullary injury can be
estimated by TMAO, the etiology of this injury remains
undetectable. For instance, significantly elevated blood
TMAO levels were demonstrated in rats treated with clin-
ically relevant cyclosporine doses when compared to con-
trols [15]. Of note is that observed TMAO blood levels
in this study are 3 to 5 times (24-hour and 42-hour, re-
spectively) higher than levels reported by our group for
cyclosporine toxicity. In contrast, using the same NMR
protocol as in the present study, allantoin was not de-
tected after cyclosporine treatment, indicating a com-
pletely different magnitude of oxidative stress [15]. In
addition, our previous report [18] demonstrated that al-
lantoin levels were less elevated (in both kidney as well
as blood tissues) when donors were pretreated with N-
acetyl-cysteine, a putative free radical scavenger that is
known to ameliorate oxidative stress. It is possible that
further evaluation of metabolic blood profiles may allow
for the distinction not only between IR and drug toxicity
but also rejection. There are no 1H-NMR–based stud-
ies of blood that reliably distinguish rejection from other
pathologies.
In view of our promising data, it would be worthwhile
to perform a prospective clinical study using quantita-
tive metabolomics. In this study, kidney transplant pa-
tients with elevated SCr levels would undergo blood
sampling for assessment of their metabolic profiles.
These metabolic “fingerprints” could then be correlated
with the histologic findings previously obtained by renal
biopsy. One could then determine early metabolic pro-
files to predict and to differentiate between IR injury,
rejection, and drug toxicity.
CONCLUSION
In the present study, we were able to demonstrate
the correlation of metabolic markers that indepen-
dently serve as surrogates for oxidative stress and renal
medullary injury. Unlike SCr values, which were not dif-
ferent between transplant groups, the distribution of al-
lantoin and TMAO in blood or allantoin and PUFA in
kidney tissue (Fig. 3) was significantly different between
groups and demonstrated no overlap between 24 and
42 hours of cold ischemia. Metabolic patterns were also
consistent in terms of the severity of histologic damage.
Nuclear magnetic resonance spectroscopy is well suited
to identify and, more importantly, to quantify metabolic
profiles under different conditions. A metabolic blood
profile that was based on the correlation of independent
markers of oxidative stress (allantoin) and medullary in-
jury (TMAO) instead of nonspecific SCr was able to
quantify the severity of IR injury in a rat kidney trans-
plant model. An important future clinical application of
quantitative metabolomics may be the distinction be-
tween IR injury, early rejection, chronic rejection, and
drug nephrotoxicity.
ACKNOWLEDGMENT
Supported in part by NIH R01 DK065094-01 (N.S., J.K., and C.U.N.).
Correspondence to Claus U. Niemann, M.D., University of California
at San Francisco, Department of Anesthesia and Perioperative Care, 521
Parnassus Avenue, C 450, San Francisco, CA 94143–0648.
E-mail: niemannc@anesthesia.ucsf.edu
No reprints available.
Serkova et al: Allantoin in rat kidney transplantation 1151
REFERENCES
1. BOOM H, MALLAT MJ, DE FIJTER JW, et al: Delayed graft function
influences renal function, but not survival. Kidney Int 58:859–866,
2000
2. MORESO F, SERON D, GIL-VERNET S, et al: Donor age and delayed
graft function as predictors of renal allograft survival in rejection-
free patients. Nephrol Dial Transplant 14:930–935, 1999
3. DRAGUN D, HOFF U, PARK JK, et al: Prolonged cold preservation
augments vascular injury independent of renal transplant immuno-
genicity and function. Kidney Int 60:1173–1181, 2001
4. HETZEL GR, KLEIN B, BRAUSE M, et al: Risk factors for delayed
graft function after renal transplantation and their significance for
long-term clinical outcome. Transpl Int 15:10–16, 2002
5. NICHOLSON J, LINDON JC, HOLMES E: “Metabonomics”: Understand-
ing the metabolic responses of living systems to pathophysiological
stimuli via multivariate analysis of biologocal NMR spectroscopic
data. Xenobiotica 29:1181–1189, 1999
6. SETO K, IKEHIRA H, OBATA T, et al: Long-term assessment of post-
transplant renal prognosis with 31 P magnetic resonance spec-
troscopy. Transplantation 72:627–630, 2001
7. HAUET T, GIBELIN H, RICHER JP, et al: Influence of retrieval con-
ditions on renal medulla injury: Evaluation by proton NMR spec-
troscopy in an isolated perfused pig kidney model. J Surg Res 93:1–8,
2000
8. RICHER J, BAUMER TH, GIBELIN H, et al: Evaluation of renal medulla
injury after cold preservation and transplantation: noninvasive de-
termination of medullar damage by proton nuclear magnetic reso-
nance spectroscopy of urine and plasma. Transplant Proc 32:47–48,
2000
9. NICHOLSON J, WILSON ID: Opinion: Understanding ‘global’ systems
biology: Metabonomics and the continuum of metabolism. Nat Rev
Drug Discov 2:668–676, 2003
10. BRINDE J, ANTTI H, HOLMES E, et al: Rapid and noninvasive diagnosis
of the presence and severity of coronary heart disease using 1H-
NMR-based metabonomics. Nature Med 8:1439–1444, 2002
11. FOXALL PJ, MELLOTTE GJ, BENDING MR, et al: NMR spectroscopy
as a novel approach to the monitoring of renal transplant function.
Kidney Int 43:234–245, 1993
12. HAUET T, GIBELIN H, GODART C, et al: Kidney retrieval condi-
tions influence damage to renal medulla: Evaluation by proton nu-
clear magnetic resonance (NMR) pectroscopy. Clin Chem Lab Med
38:1085–1092, 2000
13. FULLER TF, FREISE CE, SERKOVA N, et al: Sirolimus delays recovery
of rat kidney transplants after ischemia/reperfusion injury. Trans-
plantation 76:1594–1599, 2003
14. SERKOVA N, JACOBSEN W, NIEMANN CU, et al: Sirolimus, but not
the structurally related RAD (everolimus), enhances the negative
effects of cyclosporine on mitochondrial metabolism in the rat brain.
Br J Pharmacol 133:875–885, 2001
15. SERKOVA N, KLAWITTER J, NIEMANN CU: Organ-specific response to
inhibition of mitochondrial metabolism by cyclosporine in the rat.
Transpl Int 16:748–755, 2003
16. PORTER C, O’DONNELL C, CRAWFORD ED, et al: Predicting the out-
come of prostate biopsy in a racially diverse population: A prospec-
tive study. Urology 60:831–835, 2002
17. BECKWITH-HALL B, HOLMES E, LINDON JC, et al: NMR-based
metabonomic studies on the biochemical effects of commonly used
drug carrier vehicles in the rat. Chem Res Toxicol 15:1136–1141,
2002
18. FULLER TF, SERKOVA N, NIEMANN CU, et al: Influence of donor
pretreatment with N-acetylcysteine on ischemia/reperfusion injury
in rat kidney grafts. J Urol 171:1296–1300, 2004
19. KOSIERADZKI M, KUCZYNSKA J, PIWOWARSKA J, et al: Prognostic sig-
nificance of free radicals: Mediated injury occurring in the kidney
donor. Transplantation 75:1221–1227, 2003
20. OEHLSCHLAGER S, ALBRECHT S, HAKENBERG OW, et al: Measure-
ment of free radicals and NO by chemiluminescence to identify the
reperfusion injury in renal transplantation. Luminescence 17:130–
132, 2002
21. PEREZ FERNANDEZ R, MARTIN MATEO MC, DE VEGA L, et al: An-
tioxidant enzyme determination and a study of lipid peroxidation
in renal transplantation. Ren Fail 24:353–359, 2002
22. SHOSKES DA, SHAHED AR, KIM S, et al: Oxidant stress and antiox-
idant capacity in urine of renal transplant recipients predict early
graft function. Transplant Proc 33:984, 2001
23. BENZIE I, CHUNG W, TOMLINSON B: Simultaneous measurement of
allantoin and urate in plasma: Analytical evaluation and poten-
tial clinical application in oxidant:antioxidant balance studies. Clin
Chem 45:901–904, 1999
24. SUEMATSU M, SUZUKI H, DELANO FA, et al: The inflammatory aspect
of the microcirculation in hypertension: Oxidative stress, leuko-
cytes/endothelial interaction, apoptosis. Microcirculation 9:259–
276, 2002
25. MIKAMI T, KITA K, TOMITA S, et al: Is allantoin in serum and urine
a useful indicator of exercise-induced oxidative stress in humans?
Free Radic Res 32:235–244, 2000
26. DEIANA M, ARUOMA OI, ROSA A, et al: The effect of ferric-
nitrilotriacetic acid on the profile of polyunsaturated fatty acids in
the kidney and liver of rats. Toxicol Lett 123:125–133, 2001
27. NIEMANN C, SAEED M, AKBARI H, et al: Close association between
the reduction in myocardial energy metabolism and infarct size:
Dose-response assessment of cyclosporine. J Pharmacol Exp Ther
302, 1123–1128, 2002
